rts logo

Why Perspective Therapeutics Inc (CATX) Stock Could See Much Higher Prices Ahead

Perspective Therapeutics Inc (AMEX: CATX) is 263.18% higher on its value in year-to-date trading and has touched a low of $0.20 and a high of $1.36 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CATX stock was last observed hovering at around $1.28 in the last trading session, with the day’s gains setting it 0.18%.

Currently trading at $1.46, the stock is 27.15% and 55.87% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.26 million and changing 14.06% at the moment leaves the stock 169.56% off its SMA200. CATX registered 139.34% gain for a year compared to 6-month gain of 433.43%. The firm has a 50-day simple moving average (SMA 50) of $68.73 and a 200-day simple moving average (SMA200) of -$19.05.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 53.88% loss in the last 1 month and extending the period to 3 months gives it a 263.18%, and is 15.87% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.60% over the week and 10.11% over the month.

Perspective Therapeutics Inc (CATX) has around 119 employees, a market worth around $856.90M and $8.84M in sales. Profit margin for the company is -270.46%. Distance from 52-week low is 612.20% and 7.35% from its 52-week high. The company has generated returns on investments over the last 12 months (-23.50%).

Perspective Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.03 with sales reaching $500k over the same period.The EPS is expected to grow by 47.06% this year, but quarterly earnings will post -94.00% year-over-year. Quarterly sales are estimated to shrink -75.80% in year-over-year returns.

Perspective Therapeutics Inc (CATX) Top Institutional Holders

55 institutions hold shares in Perspective Therapeutics Inc (CATX), with institutional investors hold 10.24% of the company’s shares. The shares outstanding are 586.92M, and float is at 391.29M with Short Float at 0.48%. Institutions hold 7.08% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 12.72 million shares valued at $8.5 million. The investor’s holdings represent 4.53% of the CATX Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 5.34 million shares valued at $3.57 million to account for 1.90% of the shares outstanding. The other top investors are Perkins Capital Management, Inc. which holds 2.67 million shares representing 0.95% and valued at over $1.79 million, while Geode Capital Management, LLC holds 0.87% of the shares totaling 2.45 million with a market value of $1.64 million.

Perspective Therapeutics Inc (CATX) Insider Activity

The most recent transaction is an insider purchase by Lantheus Alpha Therapy, LLC,the company’s10% Owner. SEC filings show that Lantheus Alpha Therapy, LLC bought 60,431,039 shares of the company’s common stock on Mar 06 ’24 at a price of $0.95 per share for a total of $57.41 million. Following the purchase, the insider now owns 116.77 million shares.

Perspective Therapeutics Inc disclosed in a document filed with the SEC on Jan 30 ’24 that Williamson Robert F III (Director) bought a total of 127,206 shares of the company’s common stock. The trade occurred on Jan 30 ’24 and was made at $0.71 per share for $90710.0. Following the transaction, the insider now directly holds 0.34 million shares of the CATX stock.

Still, SEC filings show that on Jan 29 ’24, Williamson Robert F III (Director) acquired 25,266 shares at an average price of $0.64 for $16170.0. The insider now directly holds 211,555 shares of Perspective Therapeutics Inc (CATX).

Related Posts